Topic: Biotech
Moira interviews Matt Gardner, President & CEO, BayBIO, the Northern California Life Sciences Organization, about the organization's the new free online Impact 2009 Report about all the biotech companies in California and everything they are working on.
Biofuels offer an environmental sustainability substitute against petrol-based fuels such as gasoline, yet they are still expensive to produce and are causing a steep inflation in food prices the world over. This panel discussion of experts debates the root causes of the increase in food prices, and the need to tackle the economic and political side effects of biofuel production.
Dr. Moira Gunn interviews Craig Wheeler, CEO of Moementa Pharmaceuticals, who discusses biologics and the new biosimilars bill in Congress.
Dr. Moira Gunn interviews David Ewing Duncan about his work in trying to help develop a personalized medicine project. He talks about how it is possible to have a project in place within ten years, using the human genome project example, where scientists worked together on a worldwide basis to accomplish a complex task.
Moira interviews Dr. Joe Miletich, Senior Vice President, R&D, Amgen, about how new DNA technologies are changing on-going scientific studies. She also speaks with Carlos Riva, CEO, Verenium Corporation, about how ethanol is moving from small farms to full commercialization.
Dr. Moira Gunn interviews Alva Noe, author of the book Out of Our Heads: Why You Are Not Your Brain, and Other Lessons from the Biology of Consciousness, in which he challenges the assumptions underlying neuroscientific studies of consciousness.
Dr. Moira Gunn interviews David Ewing Duncan, author of the book Experimental Man: What One Man's Body Reveals about His Future, Your Health, and Our Toxic World, in which he became the ultimate guinea pig, putting every aspect of his physical makeup under the microscope.
Can environmental sustainability be supported by genetics? In this audio interview, Craig Venter, a pioneer in genetic research, discusses some of his key discoveries that are advancing the state of science in genomics and synthetic life. He shares how, in his current work on DNA programming and building synthetic organisms, he is using the building blocks of life to approach society's most pressing problems such as energy and food.
Dr. Moira Gunn talks with Cliff Reid, Chairman of Complete Genomics about DNA data and large scale genome studies. He discusses how his company's high quality, affordable DNA sequencing enables commercial-scale research of the genetic mechanisms underlying drug responses and complex diseases.
Dr. Moira Gunn speaks with John Holady of QRX Pharma. He reviews the company's work in creating new applications for old blockbuster drugs.
